Valeant Pharmaceuticals (VRX) Stock: Will We See More Gains?
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) Valeant Pharmaceuticals has been struggling for quite some time, and for an incredibly good reason. The company has had several accounting errors and had an iffy-at-best relationship with an underground pharmacy known as Philidor. Soon, Citron started to call VRX the Enron of the biotechnology industry as it brought … Read more